On March 11, 2024, Wood Lay, an analyst at Keefe, Bruyette & Woods, affirmed an Outperform rating for First Western...

On March 11, 2024, analyst Peter Heckmann from DA Davidson reiterated a Buy rating on Guidewire Software (NYSE: GWRE) and...

Analyst Brian Holland from DA Davidson continues to support Vital Farms (NASDAQ: VITL) with a Buy rating and a revised...

Aprea Therapeutics has recently been granted FDA approval for its Investigational New Drug (IND) application for APR-1051, a cutting-edge WEE1...

Aprea Therapeutics, a cutting-edge biopharmaceutical company, has recently unveiled a private placement financing round expected to reach $34 million. Spearheaded...

Acelyrin has just released exciting top-line results from their global Phase 2B/3 trial of Izokibep in psoriatic arthritis, hitting the...

Gilead Sciences, Inc. has successfully completed the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 for its cash...

Piper Sandler analyst Ian Macpherson has reiterated a Neutral rating on Transocean (NYSE: RIG) on March 11, 2024. Macpherson has...

James Defranco, Director of EchoStar Corporation, made a significant investment on March 11, 2024, by purchasing 90,000 shares of EchoStar...

Bruker has unveiled groundbreaking advancements in 4D-Proteomics timsTOF technology, setting a new standard for proteomics applications. These cutting-edge capabilities were...